#Icad inc stock skin

for early-stage breast cancer, endometrial cancer and skin cancer, as well as other varieties where radiation therapy is indicated, the initial report on the acquisition stated. It acquired Xoft's Axxent system which delivers radiation therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue, according to the company. In December 2010, iCAD expanded the companyвЂ™s oncology footprint by acquiring Xoft, Inc. ICad originally focused on image-analysis products designed to help radiologists and other health-care providers detect cancers early. These acquisitions brought together two of the three companies with FDA clearance to market CAD solutions for breast cancer in the United States.

of Ohio and its subsidiary, CADx Systems, Inc. Subsequently, the company acquired Qualia Computing, Inc. (ISSI) which had developed an approved computer-aided detection system for breast cancer. The company acquired Intelligent Systems Software, Inc. In 2001, foreseeing a decline in the graphic arts and photo finishing industries, Howtek elected to focus solely on the medical imaging market. From 1984 to 2000 Howtek successfully developed a series of products that improved the quality of digital imaging while reducing the price and complexity of digitizing systems. The scanners converted printed, photographic and other hard copy images to digital form for use in the graphic arts, photo finishing and medical industries. Howtek developed, manufactured and marketed digitizing systems or scanners. iCAD provides a range of CAD solutions for mammography and computed tomography for colorectal cancer. iCAD offers computer-aided detection (CAD) technologies, advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. The iCAD brand includes two distinct business units that provide tools for detection, diagnosis and treatment of cancers. 2.2 Tungsten particles left in test subjects.

Icad inc stock